Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

    Develop new screening methods and treatments for newborns with potentially fatal or disabling disorders identified through newborn screening, focusing on high priority genetic conditions with potential for future screening.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

    Funding for innovative methods to screen and treat potentially fatal disorders in newborns, including genetic conditions needing screening advancements.

    HHS-NIH11Due Feb 5, 2027

    Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

    Study the natural history of newborn screening disorders to improve treatment, genetic understanding, and outcomes for infants.

    HHS-NIH11Due Feb 5, 2027

    Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

    NIH supports clinical projects that prepare rare disease therapies or diagnostics for trials through biomarkers, outcome measures, or disease characterization; clinical trials are not allowed.

    HHS-NIH11Due Feb 17, 2027$275,000

    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

    Funding for research on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD) across the lifespan with the aim of reducing prenatal alcohol exposure and advancing intervention methods.

    HHS-NIH11Due Jan 7, 2027$450,000

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

    Research grant to develop and test new psychosocial interventions for mental disorders, with focus on experimental therapeutics to translate basic science into treatments.

    HHS-NIH11Due Feb 17, 2027